Enter the game-changing implant technology that’s transforming sleep apnea treatment. Two notable options have emerged: Genio Nyxoah and Inspire. These devices offer a novel approach to managing ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists ...

Following weight loss, these patients could become more likely to benefit from Inspire. All in all, the population of people diagnosed with sleep apnea is very large, and we believe Inspire is ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for people with sleep apnea. Host Dr. Justin Clark and his guests ...

Nyxoah, founded by Robert Taub, is led by Olivier Taelman and focuses on the Genio implant, which offers a less intrusive alternative to CPAP and Inspire Therapy. Despite a high burn rate ...

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA ...